9 research outputs found

    26th Annual Computational Neuroscience Meeting (CNS*2017): Part 3 - Meeting Abstracts - Antwerp, Belgium. 15–20 July 2017

    Get PDF
    This work was produced as part of the activities of FAPESP Research,\ud Disseminations and Innovation Center for Neuromathematics (grant\ud 2013/07699-0, S. Paulo Research Foundation). NLK is supported by a\ud FAPESP postdoctoral fellowship (grant 2016/03855-5). ACR is partially\ud supported by a CNPq fellowship (grant 306251/2014-0)

    Experimental field exclosure of birds and bats in agricultural systems ? Methodological insights, potential improvements, and cost-benefit trade-offs

    No full text
    Experimental exclosure of birds and bats constitutes a powerful tool to study the impacts of wildlife on pests and crop yields in agricultural systems. Though widely utilized, exclosure experiments are not standardized across studies. Indeed, key differences surrounding the design, materials, and protocols for implementing field-based exclosure experiments of flying vertebrates increase heterogeneity across studies, and limit our understanding of biodiversity-friendly land use management. We reviewed the available literature on studies in which bird and bat exclosures were applied to study pest control in agricultural settings, and isolated 30 studies from both tropical and temperate land use systems, involving 12 crop types across 14 countries. Focusing on exclosure effects on crop yield, we analyzed effect detectability for a subset of suitable data. We then analyzed the potential of exclosure methods and possible extensions to improve our understanding of complex food webs and ecosystem services affecting the productivity of agricultural systems. While preferences exist in materials (e.g., nylon nets and bamboo frames), experimental exclosure studies of birds and bats differed greatly in their respective design, related costs, and effort ? limiting the generalization and transferability of results at larger spatial scales. Most studies were based on experiments conducted in the United States and the Neotropics, mainly in coffee and cacao farms. A lack of preliminary or long-term data with repeated measurements makes it impossible to apply power analysis in most studies. Common constraints include, among other things, the choice of material and experimental duration, as well as the consideration of local versus landscape factors. We discuss such limitations, related common pitfalls, and options for optimization to inform improved planning, design, and execution of exclosure studies. By doing so, we aim to promote more comparable and transferable approaches in future field research on biodiversity-mediated ecosystem services

    Clinical characteristics and outcomes of patients with adult congenital heart disease listed for heart and heart-lung transplantation in the Eurotransplant region

    No full text
    BACKGROUND: The therapeutic success in patients with congenital heart disease (CHD) leads to a growing number of adults with CHD (adult CHD [ACHD]) who develop end-stage heart failure. We aimed to determine patient characteristics and outcomes of ACHD listed for heart transplantation. METHODS: Using data from all the patients with ACHD in 20 transplant centers in the Eurotransplant region from 1999 to 2015, we analyzed patient characteristics, waiting list, and post-transplantation outcomes. RESULTS: A total of 204 patients with ACHD were listed during the study period. The median age was 38 years, and 62.3% of the patients were listed in high urgency (HU), and 37.7% of the patients were in transplantable (T)-listing status. A total of 23.5% of the patients died or were delisted owing to clinical worsening, and 75% of the patients underwent transplantation. Median waiting time for patients with HU-listing status was 4.18 months and with T-listing status 9.07 months. There was no difference in crude mortality or delisting between patients who were HU status listed and T status listed (p = 0.65). In multivariable regression analysis, markers for respiratory failure (mechanical ventilation, hazard ratio [HR]: 1.41, 95% CI: 1.11-1.81, p = 0.006) and arrhythmias (anti-arrhythmic medication, HR: 1.42, 95% CI: 1.01-2.01, p = 0.044) were associated with a higher risk of death or delisting. In the overall cohort, post-transplantation mortality was 26.8% after 1 year and 33.4% after 5 years. CONCLUSIONS: Listed patients are at high risk of death without differences in the urgency of listing. Respiratory failure requiring invasive ventilation and possibly arrhythmias requiring anti-arrhythmic medication indicate worse outcomes on waiting list

    Study design and rationale of the pAtients pResenTing with cOngenital heaRt dIseAse Register (ARTORIA‐R)

    No full text
    Aim: Due to improved therapy in childhood, many patients with congenital heart disease reach adulthood and are termed adults with congenital heart disease (ACHD). ACHD often develop heart failure (HF) as a consequence of initial palliative surgery or complex anatomy and subsequently require advanced HF therapy. ACHD are usually excluded from trials evaluating heart failure therapies, and in this context, more data about heart failure trajectories in ACHD are needed to guide the management of ACHD suffering from HF. ----- Methods and results: The pAtients pResenTing with cOngenital heaRt dIseAse Register (ARTORIA-R) will collect data from ACHD evaluated or listed for heart or heart-combined organ transplantation from 16 countries in Europe and the Asia/Pacific region. We plan retrospective collection of data from 1989-2020 and will include patients prospectively. Additional organizations and hospitals in charge of transplantation of ACHD will be asked in the future to contribute data to the register. The primary outcome is the combined endpoint of delisting due to clinical worsening or death on the waiting list. The secondary outcome is delisting due to clinical improvement while on the waiting list. All-cause mortality following transplantation will also be assessed. The data will be entered into an electronic database with access to the investigators participating in the register. All variables of the register reflect key components important for listing of the patients or assessing current HF treatment. ----- Conclusion: The ARTORIA-R will provide robust information on current management and outcomes of adults with congenital heart disease suffering from advanced heart failure

    Study design and rationale of the pAtients pResenTing with cOngenital heaRt dIseAse Register (ARTORIA-R)

    No full text
    corecore